Lidoflazine
Lidoflazine is a piperazine calcium channel blocker. It is a coronary vasodilator with some antiarrhythmic action.[1] Lidoflazine was discovered at Janssen Pharmaceutica in 1964.
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.020.285 |
Chemical and physical data | |
Formula | C30H35F2N3O |
Molar mass | 491.627 g·mol−1 |
3D model (JSmol) | |
Melting point | 159 to 161 °C (318 to 322 °F) |
Solubility in water | Almost insoluble in water(<0.01%); Very soluble in chloroform(>50%); mg/mL (20 °C) |
| |
| |
|
Physical properties
Solubility at room temperature
Extracted from[1]
Solvent | 0.01
N |
0.1
N | ||
% | pH | % | pH | |
Hydrochloric Acid | 0.4 | 3.0 | 0.7 | 1.9 |
Tartaric Acid | 0.3 | 3.1 | 1.0 | 2.5 |
Citric Acid | 0.3 | 3.1 | 0.5 | 2.5 |
Lactic Acid | 0.2 | 3.4 | 0.7 | 2.9 |
Acetic Acid | 0.1 | 3.5 | 0.4 | 3.8 |
gollark: I have NEVER heard of THAT eitHer.
gollark: ,,,,,,,,,,,··̣̣
gollark: NO
gollark: We're just *talking* about θ', not *defining* it, it's totally fine.
gollark: I am not aware of "calculus of variations".
References
- Schaper WK, Xhoneux R, Jageneau AH, Janssen PA (May 1966). "The cardiovascular pharmacology of lidoflazine, a long-acting coronary vasodilator". The Journal of Pharmacology and Experimental Therapeutics. 152 (2): 265–74. PMID 5944369.
Further reading
- Schaper WK, Xhonneux R, Jageneau AH (November 1965). "Stimulation of the coronary collateral circulation by lidoflazine (R 7904)". Naunyn-Schmiedebergs Archiv Fur Experimentelle Pathologie und Pharmakologie. 252 (1): 1–8. doi:10.1007/bf00246424 (inactive 2020-05-29). PMID 4222721.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.